New Delhi: Indian Medical Fair (MFI 2019) fully underlined the capability of Indian companies for making medical devices. ‘Make in India’ pavilion unveiled hope that given government’s affirmative policies, Indian companies can give overseas Majors a run for their money, saving an import bill of over Rs 31, 000 crore.
AiMeD (Association of Indian Medical Device) was in the vanguard showcasing, immense potential of India. In the 3 day fair in Pragati Maidan starting from February 21, over 250 Indian exhibitors participated. It underlined the strong urge to bring India in the big league of globally Top 5 Medical Devices manufacturing hubs.
The 25th Medical Fair India boasted a total of 600 exhibitors. It is India’s no 1 Trade Fair for Hospitals, Health Centres and Clinics. It is continuously on growth trajectory and is on course to assume the level of iconic medical fairs, keeping pace with the positive trend in the industry. Medical Fair India 2018 in Mumbai between 16 – 18 March saw 12,350 trade visitors and this years it crossed 15,000 trade visitors.
Make in India and AIMED’s pavilion at MFI 2019 showcased the immense potential of India, its high precision engineering yet affordable, technologically advanced design, innovation, manufacturing and export hub raising high the brand India flag.
The display included: medical products and devices, laboratory technology and diagnostics, clinic and health centre furniture, and the health IT segments now so on trend the world over as well as mobile health solutions.
‘India is one of the fastest growing countries in Medical & Healthcare Sector. Medical Fair India provides plenty of opportunity for interacting with people of different trade and business at a single place to set up profitable business relationships and keep abreast with accessible technologies,’ said Mr Rajiv Nath, Forum Coordinator, AiMeD.
Addressing International Conference at MFI 2019, Rajiv Nath further said, ‘Medical Fair India is getting bigger and better with every edition. With MFI 2019, we seek Medical Devices Law to regulate quality and ensure patient safety, revision of DPCO (Drug Price Control Ordesrs) to enable rationalised price controls to protect consumers by capping trade margins over import landed, tariff at 15-20% to be in line with mobile phone so that make in Indian can prosper along with other regulatory framework, favourable policies and ecosystem support. We invite colleagues and fellow exhibitors of this global village to invest in India by technical collaborations, Joint Ventures and own factories to explore this incredible market place.’
‘I heartily congratulate all participants and want to offer my gratitude to Mr. Thomas Schlitt, Managing Director, Messe Dusseldorf India, Medical Fair India for his genuine efforts for the establishment and growth of Indian Medical and Healthcare Industry. We hope that Medical Fair India can become the preferred Healthcare Exhibition for Indian Medical Devices Industry and rise to the levels of Arab Health, Dubai and Medica, Germany, one day.’ added Mr. Nath.
Mr. Rajiv Nath also highlighted key recommendations to place India among the Top 5 Medical Devices manufacturing hubs worldwide and end the 70-90% import dependence forced upon us and an import bill of over Rs 31, 000 crore:
1- Medical Devices Law to regulate quality and ensure patient safety
2- Revision of DPCO to enable rationalised price controls to protect consumers by capping Trade Margins over import landed and ex -factory price
3- Tariff at 15-20% to be in line with mobile phone so Make in Indian and Made in India will prosper.
